Other languages Genmab A/S BOERSE MUENCHEN

Equities

GE9

DK0010272202

Real-time BOERSE MUENCHEN Other stock markets 04:14:09 2024-07-17 am EDT			5-day change	1st Jan Change
245.4 ^EUR	-0.73%		+4.13%	-14.32%

Jul. 15	RBC Capital Upgrades Genmab to Outperform	MT
Jul. 15	GENMAB : RBC raises its recommendation	CF

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

GENMAB : RBC relève sa recommandation	Jul. 15
AVIS D'ANALYSTES DU JOUR : Renault, Dassault Systèmes, Lufthansa, ArgenX, Ocado, Valeo...	Jul. 15
OPINIONI DEGLI ANALISTI DEL GIORNO : Credito Emiliano, Bper Banca, Leonardo, Credito Emiliano, Generali, Tenaris, Geberit, Repsol, Renault, Lufthansa...	Jul. 15
OPINIONES DE LOS ANALISTAS DEL DÍA : Aena, Sabadell, CaixaBank, Enagás, Endesa, Iberdrola, Prosegur Cash, Repsol, Renault, Dassault Systèmes, Lufthansa...	Jul. 15
AVIS D'ANALYSTES DU JOUR : Axa, Dassault Systèmes, ArcelorMittal, Worldline, Safran, Amundi...	Jul. 10
Les marchés branchés sur courant alternatif	Jul. 10
Borsa di Italia: Mercati collegati alla corrente alternata	Jul. 10
OPINIONES DE LOS ANALISTAS DEL DÍA : Acerinox, Aena, Amadeus, Sabadell, Santander, Bankinter, Caixabank, Axa, ArcelorMittal, Safran, Flatexdegiro, Amundi...	Jul. 10
Bolsa de Madrid: Mercados conectados a la corriente alterna	Jul. 10
Ambu A/S: Un líder innovador en equipos médicos de un solo uso	Jul. 02
Genmab, AbbVie's Lymphoma Therapy Recommended for Approval in EU	Jun. 28
AbbVie, Genmab Receive Positive European Opinion on Marketing Authorization for Possible Lymphoma Treatment	Jun. 28
En Direct des Marchés : Renault, L'Oréal, Schneider Electric, Atos, Nokia, Meta Platforms...	Jun. 28
Vous reprendrez bien un peu d'inflation ?	Jun. 28
Genmab A/S Announces Epcoritamab Receives Positive CHMP Opinion for Treatment of Adults with Relapsed/ Refractory Follicular Lymphoma	Jun. 28
AbbVie Receives Positive CHMP Opinion for Epcoritamab for the Treatment of Adults with Relapsed/Refractory Follicular Lymphoma	Jun. 28
Bolsa de Madrid: ¿Le apetece un poco más de inflación?	Jun. 28
Genmab Closes DKK3.5 Billion Share Buyback Early	Jun. 28
Genmab Gets FDA Approval for Follicular Lymphoma Treatment	Jun. 27
Genmab Wins US Approval for Follicular Lymphoma Treatment	Jun. 27

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

GENMAB : A good start to 2024; guidance unchanged

May 03, 2024 at 01:08 pm EDT